Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). (2020)

First Author: Yiu ZZN


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjd.18981

PubMed Identifier: 32124442

Publication URI: http://europepmc.org/abstract/MED/32124442

Type: Journal Article/Review

Volume: 183

Parent Publication: The British journal of dermatology

Issue: 2

ISSN: 0007-0963